Apple [AAPL] vs Core Scientific [CORZ] Detailed Stock Comparison
Apple
NASDAQ
Loading...
Core Scientific
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Apple wins in 10 metrics, Core Scientific wins in 7 metrics, with 0 ties. Apple appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Apple | Core Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.23 | -3.27 | Core Scientific |
| Price-to-Book Ratio | 52.39 | -4.29 | Core Scientific |
| Debt-to-Equity Ratio | 154.49 | -1.09 | Core Scientific |
| PEG Ratio | 2.90 | 0.03 | Core Scientific |
| EV/EBITDA | 24.64 | -90.09 | Core Scientific |
| Profit Margin (TTM) | 24.30% | 23.71% | Apple |
| Operating Margin (TTM) | 29.99% | -28.13% | Apple |
| EBITDA Margin (TTM) | 29.99% | N/A | N/A |
| Return on Equity | 149.81% | 160.33% | Core Scientific |
| Return on Assets (TTM) | 24.55% | -6.74% | Apple |
| Free Cash Flow (TTM) | $108.81B | $-52.30M | Apple |
| Dividend Yield | 0.62% | N/A | N/A |
| 1-Year Return | 1.37% | 39.05% | Core Scientific |
| Price-to-Sales Ratio (TTM) | 8.43 | 12.78 | Apple |
| Enterprise Value | $3,491.37B | $4.92B | Apple |
| EV/Revenue Ratio | 8.54 | 14.11 | Apple |
| Gross Profit Margin (TTM) | 46.49% | 6.39% | Apple |
| Revenue per Share (TTM) | $27 | $1 | Apple |
| Earnings per Share (Diluted) | $6.59 | $-1.73 | Apple |
| Beta (Stock Volatility) | 1.17 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Apple vs Core Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Apple | -0.18% | 1.92% | 9.88% | 16.10% | -4.01% | -4.80% |
| Core Scientific | 0.00% | 5.90% | 8.79% | 34.24% | 28.58% | -0.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Apple | 1.37% | 48.99% | 91.91% | 749.71% | 2,412.34% | 13,969.09% |
| Core Scientific | 39.05% | 314.74% | 314.74% | 314.74% | 314.74% | 314.74% |
Performance & Financial Health Analysis: Apple vs Core Scientific
| Metric | AAPL | CORZ |
|---|---|---|
| Market Information | ||
| Market Cap | $3.45T | $4.45B |
| Market Cap Category | Mega cap | Mid cap |
| 10 Day Avg. Volume | 38,652,350 | 16,174,142 |
| 90 Day Avg. Volume | 55,486,430 | 15,740,237 |
| Last Close | $232.14 | $14.35 |
| 52 Week Range | $169.21 - $260.10 | $6.20 - $18.63 |
| % from 52W High | -10.75% | -22.97% |
| All-Time High | $260.10 (Dec 23, 2024) | $18.63 (Nov 25, 2024) |
| % from All-Time High | -10.75% | -22.97% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | -0.44% |
| Quarterly Earnings Growth | 0.09% | -0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.24% |
| Operating Margin (TTM) | 0.30% | -0.28% |
| Return on Equity (TTM) | 1.50% | 1.60% |
| Debt to Equity (MRQ) | 154.49 | -1.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.43 | $-3.51 |
| Cash per Share (MRQ) | $3.73 | $1.90 |
| Operating Cash Flow (TTM) | $108.56B | $12.92M |
| Levered Free Cash Flow (TTM) | $94.87B | $-125,378,624 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.62% | N/A |
| Last 12-Month Dividend | $1.27 | N/A |
Valuation & Enterprise Metrics Analysis: Apple vs Core Scientific
| Metric | AAPL | CORZ |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.23 | -3.27 |
| Forward P/E | 27.94 | 47.04 |
| PEG Ratio | 2.90 | 0.03 |
| Price to Sales (TTM) | 8.43 | 12.78 |
| Price to Book (MRQ) | 52.39 | -4.29 |
| Market Capitalization | ||
| Market Capitalization | $3.45T | $4.45B |
| Enterprise Value | $3.49T | $4.92B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.54 | 14.11 |
| Enterprise to EBITDA | 24.64 | -90.09 |
| Risk & Other Metrics | ||
| Beta | 1.17 | N/A |
| Book Value per Share (MRQ) | $4.43 | $-3.51 |
Financial Statements Comparison: Apple vs Core Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AAPL | CORZ |
|---|---|---|
| Revenue/Sales | $95.36B | $79.53M |
| Cost of Goods Sold | $50.49B | $71.31M |
| Gross Profit | $44.87B | $8.21M |
| Research & Development | $8.55B | N/A |
| Operating Income (EBIT) | $29.59B | $-42.59M |
| EBITDA | $32.25B | $-641.64M |
| Pre-Tax Income | $29.31B | $580.90M |
| Income Tax | $4.53B | $205,000 |
| Net Income (Profit) | $24.78B | $580.69M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AAPL | CORZ |
|---|---|---|
| Cash & Equivalents | $28.16B | $697.94M |
| Total Current Assets | $118.67B | $833.18M |
| Total Current Liabilities | $144.57B | $195.51M |
| Long-Term Debt | $78.57B | $1.17B |
| Total Shareholders Equity | $66.80B | $-181.51M |
| Retained Earnings | $-15.55B | $-3.15B |
| Property, Plant & Equipment | N/A | $610.44M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AAPL | CORZ |
|---|---|---|
| Operating Cash Flow | $23.95B | $590.74M |
| Capital Expenditures | $-3.07B | $-88.42M |
| Free Cash Flow | $20.88B | $-129.06M |
| Debt Repayment | $976.00M | $-4.46M |
| Common Stock Repurchase | $-25.90B | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AAPL | CORZ |
|---|---|---|
| Shares Short | 127.08M | 66.35M |
| Short Ratio | 2.08 | 3.95 |
| Short % of Float | 0.01% | 0.22% |
| Average Daily Volume (10 Day) | 38,652,350 | 16,174,142 |
| Average Daily Volume (90 Day) | 55,486,430 | 15,740,237 |
| Shares Outstanding | 15.12B | 292.61M |
| Float Shares | 14.81B | 277.96M |
| % Held by Insiders | 0.02% | 0.07% |
| % Held by Institutions | 0.64% | 0.94% |
Dividend Analysis & Yield Comparison: Apple vs Core Scientific
| Metric | AAPL | CORZ |
|---|---|---|
| Last 12-Month Dividend | $1.27 | N/A |
| Last 12-Month Dividend Yield | 0.62% | N/A |
| 3-Year Avg Annual Dividend | $0.98 | N/A |
| 3-Year Avg Dividend Yield | 0.13% | N/A |
| 3-Year Total Dividends | $2.94 | N/A |
| Ex-Dividend Date | Aug 11, 2025 | N/A |